Double-blind placebo-controlled study of sublingual immunotherapy with house dust mite extract (D.Pt.) in children

Pediatric Allergy and Immunology

Volumn 8, Issue 1, 1997, Pages 21-27

  Hirsch, Th ^a   Sahn M ^a   Leupold, W ^a  

^a UNIVERSITY HOSPITAL CARL GUSTAV CARUS   (Germany)

Author keywords

Allergic rhinoconjunctivitis; Asthma; House dust mite; Sublingual immunotherapy

Indexed keywords

HOUSE DUST ALLERGEN; IMMUNOGLOBULIN G; IMMUNOGLOBULIN G4;

ADOLESCENT; ARTICLE; BRONCHUS REACTIVITY; CHEEK MUCOSA; CHILD; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; EDEMA; FEMALE; HOUSE DUST; HOUSE DUST ALLERGY; HUMAN; IMMUNOTHERAPY; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SKIN SENSITIVITY; SKIN TINGLING; SUBLINGUAL DRUG ADMINISTRATION;

EID: 0030859918     PISSN: 09056157     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1399-3038.1997.tb00138.x     Document Type: Article

References (14)

1. MALLING H-J, WEEKE B. Position paper. Immunotherapy. Allergy 1993: 48 (SUPPL 14): 9-35.
2. CANONICA GW, BAGNASCO M, PASSALAQUA G, MOTTA C, BARTOLOMEI M, MARIANI G. Kinetics of radiolabelled allergen administered by sublingual and oral route (Abstract). J Allergy Clin Immunol 1996: 97: 230.
3. MØLLER C, DREBORG S, LANNER A, BJØRKSTEN B. Oral immunotherapy of children with rhinoconjunctivitis due to birch pollen allergy. Allergy 1986: 41: 271-9.
4. GIOVANE AL, BARDARE M, PASSALAQUA G, et al. A three year double-blind placebo-controlled study with specific oral immunotherapy to Dermatophagoides: evidence of safety and efficacy in pediatric patients. Clin Exp Allergy 1994: 24: 53-9.
5. TARI MG, MANCINO M, MONTI G. Efficacy of sublingual immunotherapy in patients with rhinitis and asthma due to house dust mite. A double-blind study. Allergol et Immunopathol 1990: 18: 277-84.
6. INTERNATIONAL CONSENSUS REPORT ON DIAGNOSIS AND MANAGEMENT OF ASTHMA. National Heart, Lung, Blood Institute, National Institutes of Health, Bethesda, Maryland 20892, Publication No.92-3091, MARCH 1992: 1.
7. VAN METRE JR TE, FRANKLIN ADKINSON JR N, KAGEY-SOBOTKA A, MARSH DG, NORMAN P, ROSENBERG GL. How should we use skin testing to quantify IgE sensitivity? J Allergy Clin Immunol 1990: 86: 583-6.
8. ZACH M. (Österreichische Gesellschaft Für Lungenerkrankungen Und Tuberkulose, Arbeitsgemeinschaft für Atemphysiologie). Empfehlungen Zur Standardisierung Der inhalativen Provokation zur Messung der Unspezifischen bronchialen Reaktivität. Prax Klin Pneumol 1986: 40: 356-64.
9. PUTTONEN E, MAASCH HJ. Measurement of blocking antibodies" to pollen antigens by radiolabelled protein A from Staphylococcus aureus. Int Arch Allergy Appl Immunol 1981: 64: 157-66.
10. COHEN J. Statistical power analysis for the behavioral sciences 2nd edn. Hillsdale, New Jersey: Lawrence Erlbaum Associates 1988: 36.
11. CRETICOS PS, NACLEIRO RM, ADKINSON NF, NORMAN PS. Efficacy, safety and kinetics of oral ragweed immunotherapy in the treatment of allergic seasonal rhinitis (Abstract). J Allergy Clin Immunol 1990: 85: 165.
12. TAUDORF E, LAURSEN LC, LANNER Å, et al. Oral immunotherapy in birch pollen hay fever. J Allergy Clin Immunol 1987: 80: 153-61.
13. TAUDORF E, LAURSEN LC, LANNER Å, et al. Specific IgE, IgG and IgA antibody response to oral immunotherapy in birch pollinosis. J Allergy Clin Immunol 1989: 83: 589-94.
14. OPPENHEIMER J, ARESON JG, NELSON HS. Safety and efficacy of oral immunotherapy with standardized cat extract. J Allergy Clin Immunol 1994: 93: 61-7.